sponsored links

FDA warns Bristol’s leukemia drug may raise lung risks (Reuters)

Sponsored Links

Reuters – Health regulators warned on Tuesday that Bristol-Myers Squibb Co’s leukemia drug Sprycel may raise the risk of a rare, but serious condition characterized by abnormally high blood pressure in the arteries of the lungs.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.